test

ANDREW TIMPSON

@Silverarc Capital Management, Llc

Latest period2024 - Q3ReportedManaged Assets$445.291MTotal holdings69
Assets growth rate5.06%Assets growth rate (2-Q avg)11.39%Continuous growth in asset value6 quarters

Portfolio positions

This chart displays the top 10 holdings in Silverarc Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Silverarc Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 6 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 445.291M in assets, with a quarterly growth rate of 5.06% and a 2-quarter average growth rate of 11.39%. The portfolio is managed by ANDREW TIMPSON, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CNTACentessa Pharmaceuticals Plc
Recent Activity
New Position
2.68%
$11.906M
744,592 shares@ $15.99 avg price
URGNUrogen Pharma Ltd
Recent Activity
Decreased -18.22%
2.58%
$11.444M
901,129 shares@ $12.7 avg price
ORICOric Pharmaceuticals Inc
Recent Activity
Increased 2.21%
2.54%
$11.27M
1.099M shares@ $10.26 avg price
PSTXPoseida Therapeutics Inc
Recent Activity
Increased 2.21%
2.37%
$10.546M
3.688M shares@ $2.86 avg price
VRNAVerona Pharma Plc
Recent Activity
Increased 14.53%
2.26%
$10.037M
348,866 shares@ $28.78 avg price
ALNYAlnylam Pharmaceuticals Inc
Recent Activity
Decreased -0.62%
2.21%
$9.839M
35,774 shares@ $275.03 avg price
GERNGeron Corp
Recent Activity
Increased 80.29%
1.84%
$8.179M
1.802M shares@ $4.55 avg price
CCCCC4 Therapeutics Inc
Recent Activity
Decreased -10.04%
1.67%
$7.398M
1.298M shares@ $5.71 avg price
SNDXSyndax Pharmaceuticals Inc
Recent Activity
Increased 2.37%
1.64%
$7.291M
378,746 shares@ $19.26 avg price
PCVXVaxcyte Inc
Recent Activity
Increased 2320%
1.56%
$6.913M
60,500 shares@ $114.27 avg price